EUVIMEDEUVIMED entdecken
Crossref

Leucocytosis during all‐ trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia

Masamitsu Yanada iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Masamitsu Yanada. Beteiligte Einrichtung: Nagoya City University East Medical Center, Nagoya, Japan. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, Arsenic Trioxide, Tretinoin, Leukocytosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In patients with acute promyelocytic leukaemia (APL), differentiation syndrome (DS) is a life‐threatening complication caused by the differentiating effect of all‐ trans retinoic acid (ATRA) and/or arsenic trioxide (ATO). Leucocytosis is frequently observed during induction therapy for APL and is intimately associated with the development of DS and its severity. The management of DS is particularly important due to the high likelihood of excellent outcomes for APL patients who successfully complete induction therapy. Commentary on: Cicconi et al. Leukocytosis during induction therapy with all‐ trans ‐retinoic acid and arsenic trioxide in acute promyelocytic leukemia predicts for differentiation syndrome and treatment‐related complications. Br J Haematol 2024; 205: 1727‐1733 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteArsenic TrioxideTretinoinLeukocytosisHumansAntineoplastic Agents

Stichwörter der Autor:innen

acute promyelocytic leukaemiaall‐trans retinoic acidarsenic trioxidedifferentiation syndromeleucocytosis

Substanzen

Arsenic TrioxideTretinoinAntineoplastic Agents

Autor:innen und Institutionen

  • Nagoya City University East Medical Center, Nagoya, Japan.

ORCID-Profile: Masamitsu Yanada

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Yanada, M. (2024). Leucocytosis during all‐ trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia. British Journal of Haematology. https://doi.org/10.1111/bjh.19763

Vancouver

Yanada M. Leucocytosis during all‐ trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia. British Journal of Haematology. 2024. doi:10.1111/bjh.19763

BibTeX
@article{Yanada2024,
  author = {Yanada, Masamitsu},
  title = {Leucocytosis during all‐ trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19763}
}
Kostenlos starten →